JP Patent

JP6310542B2 — シクロベンザプリン塩酸塩およびアミトリプチリン塩酸塩の共融製剤

Assigned to トニックス ファーマシューティカルズ， インコーポレイテッド · Expires 2018-04-11 · 8y expired

What this patent protects

Patent listed against Ubrelvy.

Drugs covered by this patent

Patent Metadata

Patent number
JP6310542B2
Jurisdiction
JP
Classification
—
Expires
2018-04-11
Drug substance claim
No
Drug product claim
No
Assignee
トニックス ファーマシューティカルズ， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.